Further analyses examined whether racial differences in the rate of change of plasma Aβ were modified by baseline amyloid status, age, sex, APOE ε4 carrier status, years of education, cognitive status, BMI, hypertension, or diabetes. The gene discussed is APOE; the disease is diabetes mellitus.